Quick summary: Expectation activates real neurochemical processes in the brain, including dopamine and endorphin release, which influence how the body responds to treatment. The nocebo effect demonstrates that negative beliefs can produce equally measurable harm through distinct neurological pathways. The doctor-patient relationship, prior treatment experience and individual factors such as genetics all shape how strongly these effects occur.
Most people have heard of the placebo effect. Fewer understand just how biologically real it is. Expectation does not merely shape how patients feel about treatment; it actively changes what happens inside the body during recovery.
Victor Vroom’s expectancy theory offers a useful starting point. The theory holds that motivation only kicks in when three things align: a person believes their effort will produce results, that those results will lead to a meaningful outcome, and that the outcome is worth having. Applied to medicine, a patient who trusts that a treatment will work, and genuinely values their health, is already in a better physiological position before any drug enters the bloodstream.
This is where the placebo effect becomes interesting. When a patient believes they are receiving effective treatment, the brain releases endorphins and dopamine. Endorphins reduce pain perception through the same opioid receptors that analgesic drugs target. Dopamine reinforces the sense that recovery is happening. MRI data shows measurable dopamine increases in the nucleus accumbens, a brain region tied to reward processing, even in patients receiving nothing pharmacologically active. Research using PET scans on healthy volunteers confirmed this directly: a placebo injection produced a clear spike in dopamine activity.
Conditioning helps explain why placebo effects persist across clinical trials. A patient who has previously experienced effective treatment may begin to respond positively to the rituals surrounding care: the clinical environment, the act of taking a pill, even the presence of a doctor. The brain, trained by past experience, begins producing a healing response before any active compound is involved. This is the same mechanism Pavlov identified in dogs, applied to human neurobiology.
The flip side is equally important. The nocebo effect, where negative expectations produce genuine physical harm, operates with the same neurological precision. When patients anticipate pain or side effects, the brain releases cholecystokinin, which travels to a midbrain structure called the lateral periaqueductal grey. This structure effectively amplifies pain sensitivity. A review of 109 placebo-controlled trials found that 19% of participants reported adverse effects during placebo administration, rising to 28% after repeated doses. How doctors describe risk is not a neutral act.
These findings sit within a broader field. Psychoneuroimmunology, the study of connections between the nervous system and the immune system, has demonstrated that psychological states such as chronic stress suppress immune function through cortisol release. Robert Ader’s foundational research showed that immune responses could be classically conditioned, meaning the brain could be trained to enhance or suppress immunity based on expectation alone. The placebo effect and the broader mind-body relationship are, in this framing, expressions of the same underlying process.
Not everyone responds to placebos in the same way. People with higher baseline anxiety tend to show stronger nocebo responses. Those with a more optimistic disposition tend to experience stronger placebo effects. Genetics also plays a role: variants of the COMT gene, which regulates dopamine metabolism, appear to predict how strongly a person responds to expectation-driven neurochemical change. Prior treatment experience matters too. Patients who have previously responded well to care show amplified placebo responses in future treatments, while those whose early experiences were negative carry stronger nocebo tendencies into subsequent consultations.
Research into open-label placebos adds another layer. Patients told they are receiving a placebo still experience benefit. This reframes the mechanism entirely: the therapeutic effect does not depend on deception. What matters is the ritual, the relationship, and the expectation surrounding treatment. A warm, confident, empathetic clinician produces better patient outcomes than a cold or uncertain one, even when both prescribe identical treatments. A study found statistically significant differences in recovery based on the quality of the doctor-patient interaction alone. The length of the consultation matters too. Patients who felt listened to reported lower anxiety after appointments, which reduced cortisol production and, in turn, supported better immune function.
None of this means that belief cures serious illness. The placebo effect is better understood as a force multiplier: it amplifies the body’s response to treatment rather than replacing treatment itself. Distorted versions of the mind-body connection already circulate widely, sometimes in ways that discourage people from seeking medical help. That is a public health problem worth naming.
What the evidence does support is that expectation functions as a biological variable, not a psychological footnote. Clinical environments, communication styles, therapeutic relationships and patient history all shape how the body responds to care. Treating that seriously is not an alternative to good medicine. It is part of what good medicine looks like.
Maithili Singhania is an undergraduate psychology student with a keen interest in the intersection of psychology and medicine. She aspires to pursue further research in the field and contribute to making psychological science more accessible to the general public.
